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Abstract
Streptococcus suis is a major bacterial pathogen of young pigs causing worldwide economic problems for the pig industry. S.
suis is also an emerging pathogen of humans. Colonization of porcine oropharynx by S. suis is considered to be a high risk
factor for invasive disease. In the oropharyngeal cavity, where glucose is rapidly absorbed but dietary a-glucans persist,
there is a profound effect of carbohydrate availability on the expression of virulence genes. Nineteen predicted or
confirmed S. suis virulence genes that promote adhesion to and invasion of epithelial cells were expressed at higher levels
when S. suis was supplied with the a-glucan starch/pullulan compared to glucose as the single carbon source. Additionally
the production of suilysin, a toxin that damages epithelial cells, was increased more than ten-fold when glucose levels were
low and S. suis was growing on pullulan. Based on biochemical, bioinformatics and in vitro and in vivo gene expression
studies, we developed a biological model that postulates the effect of carbon catabolite repression on expression of
virulence genes in the mucosa, organs and blood. This research increases our understanding of S. suis virulence mechanisms
and has important implications for the design of future control strategies including the development of anti-infective
strategies by modulating animal feed composition.
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Introduction
Streptococcus suis is a major bacterial pathogen of young pigs and
a worldwide economic problem for the pig industry. Furthermore,
S. suis is emerging as a zoonotic pathogen associated with
meningitis and septicaemia in humans [1,2]. In pigs, invasive
disease is thought to be caused by translocation of S. suis across the
mucosal epithelium in the upper respiratory tract [3,4]. The
ecological conditions that promote adhesion to, and invasion of
the host mucosa by S. suis are unknown and probably depend on
the environmental conditions and the bacterial genotype including
presence of virulence genes. In vitro studies on adhesion and
invasion by S. suis have often been performed in medium
containing glucose as a carbon source which does not accurately
reflect the situation in vivo. In the oropharyngeal cavity including
the saliva, glucose may be present but concentrations usually
diminish rapidly (within 30 min) after ingestion [5,6] as glucose is
readily absorbed by the host and metabolized by commensal
bacteria. In contrast, starch a-glucans, large polymers of D-glucose
that are present in large amounts in animal feeds [7] can persist in
high concentrations in the oropharynx of humans and pigs [8–11].
A second type of carbohydrate that may promote proliferation of
pathogenic bacteria is animal glycogen released from damaged or
lysed cells. Suilysin, a hemolytic toxin encoded by the S. suis sly
gene, may release, through its cytotoxic effect on epithelial cells,
cellular glycogen [12,13] that may serve as an important substrate
for pathogen growth during the early stages of infection.
Currently, little is known about the expression and regulation of
S. suis virulence factors such as suilysin. Streptococcal pathogens
contain genes required for efficient utilization of a-glucans
including amylases and/or pullulanases which cleave a-1,4 and
a-1,6 glycosidic bonds in starch or glycogen [14–18]. Previously,
we have shown that a cell wall anchored amylopullulanase of S.
suis serotype 2 (apuA-SSU1849) was necessary to support bacterial
proliferation on the a-glucan starch/pullulan (an a-1,6; a-1,4
linked glucose polymer) as a single carbon source and to promote
adhesion of S. suis to porcine tracheal epithelial cells [19].
As in all Gram-positive bacteria, in S. suis the expression of
carbohydrate metabolic enzymes are under the control of the
global transcriptional regulator, catabolite control protein A
(CcpA) that mediates carbon catabolite control (CCC) in presence
of a preferred sugar, usually glucose. CcpA can repress or activate
transcription by binding to cis-acting catabolite response element
(cre) sites in the gene promoter regions [20,21].
Given the relative abundance of dietary complex carbohydrates
such as a-glucans and low level of glucose in the porcine upper
oropharyngeal niche occupied by S. suis, we compared the
genome-wide effects of growth on glucose or the a-glucan
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starch/pullulan on S. suis metabolism and virulence gene
expression. We first constructed a metabolic map for S. suis and
used it to analyze the key metabolic pathways altered by growth on
glucose or pullulan. In addition to genes that play roles in
(carbohydrate) metabolic pathways, 19 virulence genes were
differentially expressed, seven of which were strongly induced
(ratios.10) by growth in pullulan compared to glucose and nine
were shown to contain a consensus cre site in their promoter
sequences. The regulation of apuA, the virulence factor most
strongly induced in pullulan compared to glucose, was investigated
in detail using qPCR analysis of gene transcripts in bacteria grown
in different carbon sources, promoter mapping and binding studies
with CcpA and a newly identified transcriptional regulator, ApuR.
The biological consequences of carbohydrate metabolism and
virulence gene expression were also assessed in an in vitro porcine
tracheal cell model using qPCR, hemolytic assays and adhesion
and invasion assays. Based on these findings we propose a model
for the transcriptional regulation of production of virulence factors
during different stages of infection dependent on a CcpA-
mediated, carbon catabolite control-dependent mechanism. To
verify the predictions of this model, the in vivo expression of apuA
and sly was measured for S. suis serotype 2 recovered from the
blood and organs of pigs infected under controlled conditions.
Materials and Methods
Bacterial strains, plasmids and culture conditions
The virulent S. suis serotype 2 strain S10 [22] and S735-pCOM1-
V10 [23] were used in this study. The genome of S. suis S10 is more
than 99% identical to the genome of S. suis 2 strain P1/7, a
sequenced reference strain of which the genome had been annotated
previously (NCBI Genome and NCBI BioProject http://www.ncbi.
nlm.nih.gov/genome/?term=Streptococcus%20suis) [24]. S. suis
was grown in Todd-Hewitt broth (THB) (Difco) or on Columbia
agar plates with 6% sheep blood (Oxoid) at 37uC under 5% CO2 for
18 hr. A complex medium (CM) (Text S1) was prepared as
previously described [19,25]. The carbohydrates were added
separately and sterilized by autoclaving at 100uC for 10 min
(pullulan) or filtration with 0.45 mM pore size filter (glucose, lactose
and maltotriose). We previously demonstrated that S. suis only grows
to high density in CM when exogenous carbohydrates are added
[19]. Growth in complex medium was determined by measurement
of turbidity at OD600 using a SpectraMax M5 reader (Molecular
Devices LLC).
RNA extraction from in vitro grown S. suis and
quantitative PCR (qPCR)
For RNA extraction, S. suis S10 was grown to exponential (e)
and early stationary (s) phase as indicated in Figure S1. Ten ml of
culture was collected and centrifugated for each time point. The
pellet was immediately frozen in liquid nitrogen until further
handling. The frozen pellet was dissolved in 600 ml RA1 reagent
(Macherey-Nagel) plus b-mercaptoethanol and lysed using a
FastPrep-24 (MP. Biomedicals, Solon, OH) for 6.0 m/sec at
20 sec. Total RNA was purified using NucleoSpin RNA II
(Macherey-Nagel). The quality and the concentration of RNA
were assessed with an Experion System (Bio-Rad) and by analysis
of the A260/A280 ratio (NanoDrop 8000 UV-Vis Spectrophotom-
eter). For qPCR, cDNA was synthesized using SuperScript VILO
(Invitrogen). Primers were designed using Oligo Program version 6
(MedProbe, Oslo, Norway) (Table S1). Quantitative PCR was
performed using a LightCycler 4.0 V and the LightCycler
FastStart DNA Master SYBR Green I Kit (Roche). Constitutive
gene expression in complex media was determined as a ratio of
target gene vs reference gene proS (Text S1) [26]. The level of proS
expression was constant at all the time points analyzed (data not
shown). Two replicates of all samples and primer pairs were
included and the experiment was performed in triplicate. Non-
template controls were included for each gene in each run.
Microarray transcriptome analysis
An S. suis oligoarray (8615 K) containing in situ synthesized 60-
mers was produced by Agilent Technologies (Santa Clara, USA),
based on the genome sequence of S. suis P1/7 [24]. A total of 7651
unique 60-mers having a theoretical melting temperature of
approximately 81uC and representing 1960 ORFs were selected as
described [27]. Genes were represented by 4 (91%), 3 (4%), 2
(2%), or 1 probe (3%). Twenty-five putative genes were not
represented on the array because no unique probe satisfying the
selection criteria could be selected. RNA (1 mg) from S. suis
samples was labeled using the Cyanine 5 (Cy5) labeling reaction
(Amersham Biosciences, Buckinghamshire, UK). Co-hybridization
with labeled cDNA probes was performed on these oligonucleotide
arrays at 42uC for 16 h in Slidehyb#1 (Ambion, Austin, USA).
The data were normalized using Lowess normalization [28] as
available in MicroPrep [29] and corrected for inter-slide
differences on the basis of total signal intensity per slide using
Postprep [29]. Significance of differential gene expression was
based on FDR values lower than 0.05. All microarray data are
MIAME compliant and available in the NCBI GEO database
(http://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE40658. Details of the custom-made 60-mer oligonucleotide
array design (Agilent Biotechnologies, Amstelveen, The Nether-
lands) are deposited in the ArrayExpress database (http://www.
ebi.ac.uk/arrayexpress/) under accession number A-MEXP-1671.
Bioinformatic tools: microarray analysis and cre motifs
search
Differential gene expression of S. suis bacteria grown in CM
supplemented with pullulan (Pul) or glucose (Glc) and harvested at
early exponential (e) or early stationary (s) phase was cross-
compared in different combinations (Pul_e vs Glc_s, Pul_s vs
Glc_s, Pul_e vs Pul_s and Glc_e vs Glc_s). Overlapping and
unique differentials were visualized using Venn diagrams at
http://bioinfogp.cnb.csic.es/tools/venny/index.html.
For all genes and proteins identified in the S. suis P1/7 genome,
Gene Ontology (GO, http://www.geneontology.org) and KEGG
pathway annotations were obtained using the BLAST2GO
software (www.blast2go.org) [30] including annotations based on
terms obtained from EBI using the InterPROScan feature [31]
that is part of BLAST2GO.
BLAST2GO was used to annotate all known S. suis genes and
proteins according to standard Gene Ontology (GO) (www.
geneontology.org) nomenclature. BLAST2GO uses the integrated
Gossip package [30] for statistical assessment of differences in GO
term abundance between two sets of sequences. The GO
enrichment analysis feature of BLAST2GO was then used to
identify functional GO terms that were statistically over- or
underrepresented in the set of genes differentially expressed in
pullulan vs glucose in exponential and early stationary phases of
growth (Fisher’s Exact Test p,0.05).
The MEME (http://meme.sdsc.edu/meme/meme.html) soft-
ware suite (version 4.1.0) was used for the identification of motifs
OM1 and OM2 [32]. As input, we used the promoter sequences of
the MdxE and MalE genes, with well-characterized cre sites, from
Bacillus and Listeria (TGWAARCGYTWNCW [W=A or T;
R=A or G; Y=C or T; N= any base]). A range of motif widths
(15 nt in length) and zero or one motif per sequence were specified
Carbohydrate Regulation of S. suis Virulence
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in our queries and FIMO, part of MEME, was used to search for
this motif in the genome of S. suis P1/7. The algorithm in MAST,
also part of the MEME suite, calculates position scores for the
motif at each possible position within a sequence [33]; motif hits
with a position-specific goodness-of-fit P value below 1024 were
considered to identify putative CcpA binding sites. In silico searches
and comparisons of predicted cre sites within the S. suis P1/7
genome sequence and reconstruction of cre locations in the
predicted operons were conducted using the corresponding
databases provided by the MicrobesOnline database web server
(http://microbesonline.org) and RegPrecise database [34].
59-Rapid Amplification of cDNA Ends (59-RACE)
The 59-rapid amplification of cDNA ends (RACE) system
(Invitrogen) was used to determine the transcription start site of the
apuA gene. Briefly, the first strand cDNA was reverse transcribed
from RNA from 1 mg of total RNA S. suis grown in CM plus
pullulan using the specific primer ASP1 (Table S1). A homopol-
ymeric tail was added to the 39-end of the cDNA using terminal
deoxynucleotidyl transferase (TdT) and the deoxynucleotide
dCTP. The tailed cDNA was amplified in nested-PCR with
Abridged Anchor Primer (AAP) and a second apuA specific primer
ASP2 primer upstream ASP1. The resulting 59-RACE product of
,380 bp was sequenced and analysed by Vector NTI software
(Invitrogen).
Recombinant regulators production and infrared EMSA
The genes encoding the regulators ApuR (amino acids 2 to 312)
and CcpA (amino acids 2 to 333) were amplified by PCR from S.
suis 2 S10 genomic DNA using GoTaq (Promega) with primers
ApuR_F/R and CcpA_F/R respectively (Table S1). The recom-
binant ApuR (rApuR) and CcpA (rCcpA) proteins were cloned in
pTrcHis TOPO2 TA and purified by HPLC affinity chromatog-
raphy (HisTrap affinity column, Amersham Pharmacia Biotech) as
previously described (Text S1) [19]. Fractions containing purified
fusion proteins of the expected size (approx. 38 kDa for ApuR and
40 kDa for CcpA) were collected and dialyzed against buffer
(500 mM NaCl, 50 mM Tris-HCl, pH 7.4) and stored at 280uC
with 10% of glycerol. Protein concentrations were measured using
a BCA Protein Assay kit (Thermo Scientific). Further details can
be found in the Text S1.
Infrared electrophoretic mobility shift assays (EMSA) were
performed utilizing three pairs of fluorescent InfraRed-dye 800
(IRdye 800) labelled primer on the 59 ends (Biolegio, The
Netherlands). The IRdye-primers used to PCR-amplify three
DNA fragments of ca. 120 bp (Pr1-Pr3) contained overlapping
regions to cover the full length of the S. suis P apuA promoter
sequence (Table S1). The IRdye-PCR fragments were purified
with QIAquick PCR Purification Kit (Qiagen) and used for the
binding reaction at a concentration of around 50 nM. DNA
binding reactions were performed in 20 ml of binding buffer
containing 10 mM Tris-HCl pH 8.5, 50 mM NaCl, 10 mM
EDTA, 0.5% Tween-20, 10 mM DTT, and 1 mg of poly(dI-dC)-
labelled IRdye-PCR fragments at room temperature for 30 min.
For the specific and non-specific competition assays, D(+)-glucose
6-phosphate (30 mM) (Sigma) was added to the binding buffer in
the EMSA as CcpA cofactor [35]. Purified rApuR and rCcpA
proteins (from 0.5 to 4.0 mM) were incubated, in separate
experiments, with the fragment Pr2 and a non-specific competitor
fragment that was obtained by PCR amplification of the gene
SSU0879 (from 25 to 150 nM). Two 95 bp oligonucleotides
complementary to Pr2 fragment lacking the two predicted binding
sites (DOM1 and DOM2/cre) were synthesized (Eurogentec, The
Netherlands), PCR-amplified with labelled Pr2F/R primers and
incubated with the proteins. Free and bound DNAs were
separated on 5% Tris-Borate-EDTA (TBE) native gels for
30 min at 10 cm/v. The gels were visualized using a LI-COR
Odyssey Imager and scanned at 800 nm wavelengths.
Titration of hemolytic activity
The hemolytic activity was assayed as previously described [36].
Two different independent assays were carried out in triplicate.
Briefly, S. suis bacteria were grown in CM+Glc and CM+Pul at
three different growth stages: lag (OD600 0.1–0.2), exponential
(OD600 0.2–0.5) and stationary (OD600 0.5–0.7). The supernatant
was collected from 1 ml for each culture by centrifugation at
12000 g for 1 min. Serial twofold dilutions (150 ml) of test samples
were prepared in polystyrene deep-well titer plates (Beckman) with
10 mM Tris-buffered saline (PBS, pH 7.4). Subsequently, 150 ml
of a 2% washed horse erythrocyte suspension in 10 mM Tris-
buffered saline containing 0.5% BSA was added to each well. After
the wells were sealed, the plates were incubated on a Coulter
mixer for 2 h at 37uC. Unlysed erythrocytes were sedimented by
centrifugation (1500 g for 10 min), 150 ml portions of the
supernatant were transferred to a polystyrene flat-bottom micro-
titer plate and measured at 540 nm with a microELISA (enzyme-
linked immunosorbent assay) reader (SpectraMax M5, Molecular
Devices LLC). A 100% lysis reference sample was obtained by
lysing cells with 1% Triton-X and the background lysis was
subtracted before calculation of hemolytic activity.
Adherence and invasion assays using NPTr cell line
Culturing of Newborn pig tracheal cells (NPTr) [37] and
adhesion assays were performed as previously described [19]. For
the invasion assays, S. suis was added to the cell culture at an
multiplicity of infection (m.o.i.) of ,50 and incubated for 2 h at
37uC with 5% CO2 to allow cellular invasion by the bacteria. The
monolayers were then washed three times with PBS; 1 ml of cell
culture medium containing 100 ml/ml gentamycin and 5 mg/ml
penicillin G was added to each well, and the plates were incubated
for 2 h at 37uC, 5% CO2 to kill extracellular and surface-adherent
bacteria. The monolayers were washed three times with PBS, and
cells were disrupted by the addition of 800 ml of ice-cold Milli-Q
water and repeated up-and-down pipetting to release intracellular
bacteria. To enumerate the viable bacteria, serial dilutions of each
cell lysate were plated in triplicate on Columbia sheep blood agar
plates and incubated at 37uC for 24 h. The rate of invasion was
expressed as percentage of initial inoculum that was recovered per
well. Two independent assays were performed in triplicate.
Experimental infection of pigs
The animal experiment described in this paper was approved by
the ethical committee of the Central Veterinary Institute of
Wageningen UR, Lelystad, The Netherlands under proposal
number 2010113c in accordance with Dutch legislation (The
Experiments on Animals Act, 1997) and the general principles
governing the use of animals in experiments of the European
Communities (Directive 86/609/EEC). To reduce unnecessary
suffering of animals, humane end points were used: piglets were
euthanized as soon as S. suis-specific symptoms occurred.
Caesarean-derived, colostrum-deprived (CDCD) piglets were
infected i.v. with 16106 CFU of S735-pCOM1-orf2 [23]. The
strain used to experimentally infect pigs was different to that used
in our in vitro qPCR assays but was selected because it was known
to be effectively recovered from the blood and organs in
experimental pig infections. Genes encoding apuA and sly are
both present in the genome of this strain (not shown). Animals
were euthanized when specific S. suis symptoms (meningitis,
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arthritis, sepsis) were observed, or at the end of the experiment (6
days post infection). After animals were euthanized; organs and
specific sites of S. suis infection were examined macroscopically
and bacteriologically. Tissue samples were collected during post-
mortem observation and snap-frozen in liquid nitrogen.
Quantitative PCR using bacterial-enriched RNA isolated
from in vivo tissues and blood
Blood collected in PAXgene tubes was treated as recommended
by the manufacturer (PreAnalytix/Qiagen). Samples taken from
heart, brain and joints consisted of a mixed pellet of porcine cells
combined with bacteria. All pellets from in vivo samples were
thawed on ice, resuspended in 600 ml of Trizol (Invitrogen,
Carlsbad, CA, USA) and subjected to 40 seconds of 6.5 m s22 in
the Fastprep-24 (MP Biomedicals, Solon, OH, USA) to disrupt
bacteria. The mixture was extracted with 120 ml of chloroform,
mixed for 15 seconds, incubated for 3 min at RT and centrifuged
for 15 min at 20.000 x g. Supernatant was removed and extracted
with 1 volume of chloroform. RNA in the supernatant was
precipitated with 1 volume of isopropanol. After incubation for
30 min at RT or 16 h at 220uC, RNA was collected by
centrifugation, and washed with 70% ethanol. The pellet was
resuspended in water. Subsequently, RNA was purified as
described above. To remove eukaryotic RNA all samples were
treated using the MicrobEnrich kit (Ambion, Austin, Tx, USA).
Bacterial-enriched RNA was amplified using the Ovation PicoSl
WTA system v2 (Nugen, San Carlos, CA, USA). cDNA was
purified using MinElute spin columns (Qiagen, Hilden, Germany)
and diluted 25 times for qPCR analysis. Primers were designed
using PrimerExpress software (Applied Biosystems, Foster City,
CA, USA) (Table S1). Each reaction contained 12.5 pmol forward
primer, 12.5 pmol reverse primer and POWR SYBR Green PCR
Master Mix (Applied Biosystems). qPCR was performed using an
ABI7500 (Applied Biosystems). As the bacterial RNA was
amplified we used a more stringent GeNorm method [38] for
normalization of the real-time qPCR data. GeNorm utilizes
multiple internal control genes for normalization, in this case gyrA,
proS, and mutS that were most stably expressed among 7 tested
genes (data not shown). In each run a standard curve was
incorporated consisting of seven 10-fold dilutions of a vector
containing the cloned target of the PCR. In this way, both target
genes and the reference genes could be related to a standard line.
For each reaction, negative water controls were included. Analysis
was performed using the ABI7500 Software (Applied Biosystems).
Statistical analysis
The results obtained in the in vitro studies were analyzed using
GraphPad Prism version 5.0 software (San Diego California,
USA). All qPCR experiments and hemolytic activity assay were
reproduced at least two times in triplicates and, where indicated,
representative experiments are shown. Two-way ANOVA tests
were carried out using Bonferroni’s post hoc test. The adhesion
and invasion assays were performed at least two times using
triplicate samples. All numerical data presented here are expressed
as means 6 standard error of the mean (SEM). Statistical
significance was determined using a two-tailed unpaired Student’s
t test. Differences were considered significant at p,0.05. Statistical
significance was indicated as follows: * p,0.05; ** p,0.01; ***
p,0.001.
Results
The switch from glucose to a-glucan starch fermentation
has pleiotropic effects on gene expression
To investigate the global effects of a shift in carbohydrate
metabolism on S. suis gene expression we compared genome-wide
transcriptomic data from exponential (e) and stationary phase (s)
cultures of S. suis in complex media (CM) supplemented with 1%
of starch/pullulan (a-1,4; a-1,6 glucan) (Pul) or glucose (Glc) as
carbon sources (Figure S1 and Table S2).
The numbers of genes differentially expressed during growth in
pullulan versus glucose were 1028 (52% of annotated genes)
during exponential growth and 1015 (51% of annotated genes)
during early stationary growth (Figure 1A). In total 738 (37% of
annotated genes) genes were differentially regulated in pullulan
compared to glucose, irrespective of the growth phase. In starch/
pullulan, 209 genes were differentially regulated between the
exponential and early stationary phases of growth; in glucose, 432
genes were differentially regulated for the same comparison
(Figure 1A).
To link gene expression data to changes in bacterial metabolic
and physiological pathways, we obtained gene ontology (GO)
functional gene annotations of all differentially expressed S. suis
P1/7 genes using BLAST2GO (see Methods) (Figure 1B). Similar
analyses were also performed for a subset of differentials, namely
all upregulated genes within the GO category ‘‘carbohydrate
metabolism’’ (Figure S2). The highest number of genes differen-
tially expressed in both growth phases participated in ‘‘carbohy-
drate metabolism’’ (18%) and ‘‘carbohydrate transport’’ (11%).
Genes in the GO category ‘‘energy reserve metabolism’’ (2% for
both growth phases) and lipid metabolism that generates the
precursors of lipoteichoic acids and membrane phospholipids
(11% for both growth phases) were also enriched when bacteria
were grown in starch/pullulan vs glucose (Figure 1B). Other
enriched GO categories included amino acid metabolic pathways
for arginine and proline.
These analyses showed that culturing S. suis in presence of these
different carbon sources leads to changes of 35–50% of the S. suis
transcriptome, affecting not only carbohydrate metabolism but
also basal metabolic and stress survival pathways. To summarize
these broad changes in global transcriptomes, we generated a
visual representation of the main carbohydrate pathway genes for
six growth conditions comparisons according to their expression
ratios (see Methods) (Figure 2A).
Comparative transcriptome analysis of S. suis grown in starch/
pullulan vs glucose revealed that growth in pullulan induced
expression of the maltodextrins utilization gene cluster that
includes apuA and the corresponding phosphotransferase systems
(PTS) and ATP-binding cassette (ABC) transporters. The expres-
sion of the glycolysis pathway genes did not change significantly
during growth in pullulan compared to glucose, suggesting that
activity of this pathway was not altered during growth in both
carbon sources. Rather, it appeared that excess intracellular
glucose was converted in glycogen as energy reserves (glycogen
biosynthesis pathways) or had entered into hexose-pentose
carbohydrate pathways as an alternative to glycolysis (sugar
interconversion and Leloir pathways) (Figure 2A). The biochem-
ical links between the differentially expressed metabolic pathways
are shown in Figure 2B; for each pathway, an extensive overview
of the main genes involved and their functions can be found in the
SI Text S2.
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Links between carbohydrate metabolism and virulence
gene regulation
We analyzed the transcriptome data to see whether the
differential fermentation of starch/pullulan and glucose affected
expression of known or predicted S. suis virulence genes. Seven
genes possibly involved in the invasion of mucosal tissues or
avoidance of host defenses by streptococcal pathogens were highly
upregulated (expression ratio.10) in starch/pullulan compared to
glucose (Table 1, Figure S3, Text S2). As CcpA in Gram-positive
bacteria controls carbohydrate metabolism, one of the most
profoundly altered categories in our microarray experiment, we
investigated the potential role of CcpA in regulating virulence gene
expression. We first used the MEME [39] and MAST [33]
algorithms to mine the genome sequence of S. suis P1/7 for
catabolite-responsive element (cre) sites, short DNA regions that
can be bound by CcpA, using the consensus B. subtilis cre sequence
[40–42].
38 potential cre sites located upstream of the start codon of
predicted proteins (P) or in proximity of the gene transcription
start site (G) were predicted to control expression of 172 genes
through interaction with CcpA (Table S3). Of the 172 genes in the
predicted CcpA regulon, 145 (84%) were differentially regulated
during growth in starch/pullulan compared to glucose (Table S3).
In Table S3 we show 38 cre sites and their downstream genes or
operons and if these were differentially expressed in pullulan
compared to glucose (our study) or in an S. suis serotype 2 DccpA
mutant compared to wild-type [43].
As expected, cre sites were commonly associated with the
predicted promoters of carbohydrate PTS and ABC transporters
(17%) and enzymes for carbohydrate metabolism (25%). Addi-
tionally, cre sites were identified in the promoters of regulators
(10%) and 9 (8%) out of the 19 virulence genes (47%) that were
differentially expressed in pullulan compared to glucose, including
sly and apuA (Table S3). As apuA is essential for growth on pullulan
and was shown to play a role in colonization of mucosal epithelia
in vitro [19] and suilysin is a major virulence factor, we sought to
understand the regulation of the encoding genes in more detail
and explore the role of CcpA in transcriptional regulation during
the switch from glucose to starch fermentation.
Expression of apuA and sly is repressed by CCR
We assessed the relative expression of apuA and sly by qPCR
when S. suis was grown in complex media supplemented with
glucose, lactose, starch/pullulan or maltotriose, all of which
supported efficient growth (Figure 3 panels A). Compared to
growth in glucose or lactose, apuA and sly transcription was
induced by growth in pullulan (up to 5.2 and 1.3 fold after 4 hours
respectively; P,0.001) and maltotriose (up to 2.2 and 0.23 after
two 2.5 hours respectively; P,0.01) (Figure 3 panels B and C).
As apuA and sly contain a conserved cre in the promoter region
(Table S3), we predicted that their transcription might be
repressed during growth on glucose but not lactose. However,
the relative level of apuA transcription in lactose was comparable to
that of transcription in glucose suggesting possible regulation by a
second transcriptional regulator. To test this hypothesis we added
Figure 1. Comparison of genome-wide transcriptomic data for exponential (e) and early stationary phase (s) cultures of S. suis
grown in pullulan (Pul) or glucose (Glc). A. Venn diagram of S. suis genes differentially regulated during growth in pullulan (Pul) vs glucose (Glc)
in the exponential (e) or stationary (s) phase. In each sector the numbers of shared or unique differentially expressed genes is indicated. B. GO term
distribution of S. suis genes differentially regulated in pullulan vs glucose in early exponential and early stationary phase. GO Enrichment analysis was
performed using BLAST2GO (P= 0.05, two-tailed Fisher’s Exact test).
doi:10.1371/journal.pone.0089334.g001
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Table 1. Confirmed and proposed S. suis virulence factors differentially expressed in pullulan (Pul) compared to glucose (Glc).
Annotation S. suis P 1/7 Protein Function Virulence Pul/Glc1 Biblio
Galactosyl/rhamnosyl transferase - SSU0520 CpsE/F CPS biosynthesis Attenuated-pig [71]
Tyrosine-protein kinase Wze - SSU0517 Cps2C CPS biosynthesis Attenuated-pig [71]
N-acetylneuraminic acid synthase - SSU0535 NeuB Sialic acid synthesis Attenuated-pig U [72]
Peptidoglycan GlcNAc deacetylase - SSU1448 PgdA Peptidoglycan Attenuated-pig D [73]
D-alanine-poly ligase - SSU0554 DltA LTA D-alanylation Attenuated-pig [74]
Fibronectin-fibrinogen binding - SSU1311 FbpS Adhesion ECM Attenuated-pig [75]
Enolase - SSU1320 Eno Adhesion ECM no Mutant [76]
Glyceraldehyde-3-P-dehydrog - SSU0153 GAPDH Adhesion ECM no Mutant U [77]
Di-peptidyl peptidase IV - SSU0187 DppIV Adhesion ECM Attenuated-mouse U [78]
Amynoacyl histidine peptidase - SSU1215 PepD Subtilisin- protease No Mutant U.10 [79]
6-phosphogluconate-dehydrogen - SSU1541 6-PGD Adhesion epithelium No Mutant [80]
Amylopullulanase - SSU1849 ApuA Adhesion epithelium Not tested U.10 [19]
Glutamine synthetase - SSU0157 GlnA Adhesion epithelium Attenuated-mouse D [81]
Streptococcal adhesin P - SSU0253 SadP Adhesion epithelium no Mutant U [82]
Arginine deaminase - SSU0580 ArcB Resistance to acidity Not tested U.10 [83]
Anchored DNA nuclease - SSU1760 SsnA DNA degradation Not tested U [84]
Cell envelope proteinase - SSU0757 SspA Subtilisin- protease Attenuated-mouse U [85]
Metallo-serine protease - SSU1773 IgAP IgA1 protease Attenuated-pig U.10 [86]
Suilysin - SSU1231 Sly Haemolysin Unaffected-pig U.10 [36]
Hyaluronate lyase - SSU1050 Hyl hyaluronidase Not tested U.10 [87]
putative oligohyaluronate lyase - SSU1048 HepI/III hyaluronidase Not tested U.10 [88]
Sortase A - SSU0925 SrtA Protein sorting Attenuated-pig [89]
Serum opacity-like factor - SSU1474 OFS Serum opacification Attenuated-pig D [90]
S-ribosyl homocysteinase - SSU0376 LuxS Quorum sensing Attenuated zebrafish D [91]
Muramidase released protein - SSU0706 MRP Unknown Unaffected-pig U [22]
Extracellular protein factor - SSU0171 Ef Unknown Unaffected-pig U [92]
Pul/Glc1 upregulated (U) or downregulated (D) expression when S. suis was grown in pullulan (Pul) compared to glucose (Glc).
doi:10.1371/journal.pone.0089334.t001
Figure 2. Transcriptome analysis of S. suis metabolism in presence of pullulan. A. Heatmap showing the effect of starch/pullulan on the
transcription of genes involved in carbohydrate metabolism and capsule production. Expression (ratios) of genes participating in different pathways
(indicated at the right of the heatmap) are shown for 6 different comparisons (indicated at the top of the heatmap). At the top of the Figure 2A, a
color scale depicts the ratio of expression during growth in pullulan vs. glucose. Red indicates induction (upregulation) of the respective genes and
blue indicates repression (downregulation) of the respective genes for each comparison. For each gene, the S. suis P1/7 locus tag and the gene name
is depicted on the right. B. Schematic representation of S. suis metabolic pathways differentially regulated in pullulan vs glucose. a-glucans (i.e.
starch/pullulan) are degraded by extracellular amylopullulanase (apuA) and the end degradation products, maltose/maltotriose and maltodextrins,
are transported by PTS for maltose/maltotriose (malT) and maltodextrin ABC transport inside the bacteria (malX, malC and malD). Maltodextrins and
maltose are most lilkely converted to glucose-1-phosphate (Glc1P) or a-glucose by 4-a-glucanotransferase and maltodextrin phosphorylase (malQ1
and glgP1 respectively). Glc1P can be metabolized in different pathways: phosphoglucomutase (pgm) isomerize glc1P to glucose-6-phosphate (glc6P)
which may enter glycolysis (violet box) where it is consequently oxidated to pyruvate (pyr). Homolactic fermentation reduces pyruvate into lactate,
whereas heterofermentative growth leads to other products, such as formate, acetate and ethanol (pyruvate metabolism, yellow box). The excess of
glc1P that cannot enter in glycolysis may be used for synthesis of glycogen as an energy reserve (light blue box). The genome of S. suis is predicted to
encode the enzymes sucrose phosphorylase gtfA, a-fructofuranosidase (interconvertase) invrtsC, and raffinose galactohydrolase, rafgH for the
interconversion of raffinose- like sugars. These enzymes participate in the starch and galactose Leloir pathway. Part of Leloir pathway (e.g. galactose-
1-phosphate uridylyltransferase, galT, and galactokinase, galK) was induced more strongly in starch/pullulan. GalT interconverts galactose-1-
phosphate (gal1-P) and UDP-Glucose (UDP-glc) to UDP-galactose (UDP-gal) and glc1P. Alternatively, UDP-glc may be converted into glucuronic acid
(glcur) by UDP-D-glucuronate (UDP-glcur) to enter in an alternative (to glycolysis) pathway for pyruvate (pyr) production. Pathway predictions were
reconstructed based on genome information, literature and database surveys (KEGG, MetaCyc). The following gene annotation was downloaded from
NCBI: galM, aldose 1-epimerase; galK, galactokinase; galE, UDP-glucose 4-epimerase; galT, galactose 1-phosphate uridylyltransferase; pgm,
Phosphoglucomutase/phosphomannomutase; pfkA, 6-phosphofructokinase; fba, fructose bisphosphate aldolase; tpiA, triosephosphate isomerase;
gapA, glyceraldehyde-3-phosphate dehydrogenase; pgk, phosphoglycerate kinase; gpmA, phosphoglyceromutase; eno, phosphopyruvate hydratase;
pyk, pyruvate kinase; ldh, L-lactate dehydrogenase; pyroX, pyruvate oxidase; ackA, acetate kinase; pfl, pyruvate formate-lyase; adlE acetaldehyde-CoA
dehydrogenase; adhE alcohol dehydrogenase; glgB, glgA glycogen synthase; glgC glucose-1-phosphate adenylyltransferase; glgP glycogen
phosphorylase.
doi:10.1371/journal.pone.0089334.g002
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starch/pullulan or maltotriose to S. suis growing exponentially in
either lactose (Figure 4A) or glucose (Figure 4B) and quantified
apuA transcription at different time points (Figure 4 panels C and
D). In medium containing lactose, both maltotriose and pullulan
strongly induced expression of apuA after 30 min (4.5 fold and 2.2
fold respectively; P,0.001; Figure 4C). In medium containing
glucose the addition of maltotriose or starch/pullulan had a small
effect on the expression of apuA; only a slight increase (1.6 fold;
P,0.05) of apuA expression was observed 30 min after addition of
maltotriose (Figure 4D). These results show that when S. suis is
growing in glucose for 30 min, apuA transcription is hardly
induced by pullulan or maltotriose but when grown in lactose for
30 min, apuA expression is strongly induced by pullulan and
maltotriose.
CcpA and ApuR bind to conserved operator motifs in the
apuA promoter
We hypothesized that the induction of apuA expression by
maltotriose was due to ApuR, a putative transcriptional regulator
upstream of apuA that possesses its own promoter and a predicted
rho-independent downstream terminator (Figure 5A). Homology
searches indicated that ApuR was a LacI/GalR type regulator
containing an N-terminus DNA-binding and a C-terminus ligand-
binding domain that can be bound by a specific sugar.
Comparison of ApuR with protein sequences in the UniProt
database revealed similarities to several transcriptional regulators
of operons (Figure S4) which comprising maltodextrin utilization
gene clusters. In the top ranking were listed for highest similarities:
BL23 YvdE (Lactobacillus casei; 53% identity) [44], MdxR (syn.
YyvdE; B. subtilis 168; 49% identity) [45,46], the activator EGD-e
Lmo2128 (Listeria monocytogenes; 47% identity) [47] (Figure 5 E–F)
and the activator MdxR (Enterococcus faecium E1162; 49% identity)
[48].
As apuA is considered a relevant virulence factor and its
regulation by different carbohydrates could be of biologic
relevance, we decided to investigate the binding of CcpA and
ApuR to operator sites in the apuA promoter. To elucidate the
apuA promoter regulatory modules we determined the transcrip-
tion start site, conducted homology searches for binding motifs of
known regulators in silico, and performed in vitro promoter binding
assays with purified transcription factors (TFs). The transcriptional
start site of the apuA transcript was determined experimentally by
59-RACE to be 31 nt upstream of the start codon. The consensus
235 element (59-TTGCAA-39) for RpoD (sigma 70) and the 210
element (59-TATATA-39) required for interaction with the RNA
polymerase and transcription initiation were found near the
expected positions upstream of the transcription start site
(Figure 5B). Visual inspection of the apuA promoter region
revealed the presence of two potential operator motifs (OMs) that
were also listed in the RegPrecise database [34]. One mdxR-like
operator motif, designated here as OM1, was found 13 bp
upstream of the 235 element; a second operator motif predicted
cre site designated OM2/cre, located at position 230 nt, overlap-
ping the conserved 235 element; this overlap could interfere with
binding of the RNA polymerase (Figure 5 C–F).
To demonstrate binding of ApuR and CcpA to the predicted
operator motifs, we expressed and purified these proteins in E. coli
with a C-terminal His-tag (Figure S5 and B) and tested DNA
binding in electrophoretic mobility shift assays (EMSA) using three
overlapping fragments of the PapuA promoter region (Pr 1–3;
approx. 120 bp in length). A single rApuR-DNA complex was
observed with promoter fragments Pr2 and Pr3 suggesting the
binding motif for ApuR lies within the 64 bp overlapping region
(Figure S6 panels A and B). The binding of ApuR to Pr2 was
shown to be concentration dependent in the range from 0.5 to
4.0 mM of rApuR (Figure S6C). The specificity of rApuR binding
to Pr2 was shown in a competition EMSA using unlabeled
competitor DNA (i.e. fragment Pr2) or an unlabeled non-specific
competitor lacking the two predicted OM1 and OM2/cre operator
binding motifs. The non-specific competitor DNA fragment had
no effect on Pr2 complex formation whereas the specific
competitor (Pr2) substantially reduced rApuR binding (Figure S6
panels D and E). To investigate whether ApuR binds to OM1 or
OM2/cre, promoter fragments lacking these motifs were synthe-
sized and tested in the EMSA (i.e. DOM1 and DOM2/cre, Table
S3 and S4). In three independent experiments we observed a lower
Figure 3. Transcriptional regulation of apuA and sly grown in
the presence of different carbon sources. A. S. suis S10 growth
curve at 37uC in CM containing 1% (w/v) of different sugars as
indicated. The graph shows the means and standard deviations from
two independent experiments. B. and C. Relative expression of apuA
and sly in S. suis grown in CM containing 1% (w/v) different sugars was
determined by qPCR. The transcript levels of apuA were measured after
2.5 hours and 4 hours of growth relative to the reference gene proS,
which is constitutively expressed at similar levels during growth in
different sugars (data not shown). The height of the bars represent
mean values for the relative expression data6 SEM from 2 independent
experiments (n = 3). Statistical significance was calculated using a two-
way ANOVA test followed by Bonferroni’s post hoc test (* p,0.05; **
p,0.01; *** p,0.001.).
doi:10.1371/journal.pone.0089334.g003
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amount of the rApuR-DNA complex with fragments lacking
DOM1 suggesting that ApuR binds most strongly to this motif. In
some experiments, complex formation was slightly reduced when
DOM2/cre was deleted, possibly due to low affinity binding of
ApuR to DOM2/cre at higher protein concentrations (Figure S6F).
Similarly, binding of CcpA to the PapuA OM2/cre that overlaps
with the predicted 235 promoter element was demonstrated by
EMSA using a fluorescent IRdye-Pr2 fragment containing the
putative cre site (Figure S6 panels G–J). An increasing amount of
an rCcpA-DNA complex was observed with an increasing
concentration of purified rCcpA (1.5 to 5 mM) (Figure S6G).
The complex could be outcompeted by addition of unlabeled Pr2
but not with non-specific competitor DNA indicating that CcpA
binds specifically to PapuA (Figure S6 panels H and I). Recombinant
CcpA also appears to bind to the DOM2/cre fragment although
less DNA/transcription factor complex is observed suggesting that
CcpA may also bind OM1 or other sequences in Pr2 with lower
affinity (Figure S6J).
Taken together, these results show that apuA expression may be
regulated via repression through CcpA-mediated carbon catabo-
lite control and via transcriptional activation through a dedicated
regulator encoded by the apuR gene.
Relief from CCR increases adhesion and invasion of S. suis
to porcine epithelial cells
As our microarray data showed increased transcription of apuA
and seven other genes predicted to play a role in S. suis adhesion
and invasion in starch/pullulan compared to glucose, we
hypothesized that culturing S. suis in pullulan as single carbon
source, thus in absence of glucose might increase its adhesion and
invasion capacity. Exponentially growing S. suis grown in CM
supplemented with 1% of glucose or pullulan were incubated with
NPTr cells for 2 h at m.o.i. of ,50 bacteria/cell. To maintain
similar conditions during the period of co-culture, the cell culture
medium was replaced with glucose-free DMEM supplemented
with either 1% glucose or pullulan during the 2 h incubation with
S. suis. In agreement with previous adhesion studies using the
NPTr cell line [19], we found that adherence of S. suis bacteria
grown in CM plus glucose was 19.461.0% of original inoculum
(averaged over 3 independent replicates). The adherence of S. suis
was significantly increased (24.961.7%; P,0.05; 3 replicates) after
growth in 1% pullulan (Figure 6A). In accordance with previous
studies using a human Hep-2 cell line [49], S. suis 2 S10 showed
low invasion capacity (0.05% of original inoculum) in glucose.
Invasiveness of S. suis was nearly 9-fold higher when grown in
Figure 4. Induction of apuA expression by putative inducers in the presence of glucose or lactose. A. Growth curves of S. suis S10 in CM
containing 1% w/v lactose or B. 1% w/v glucose before and after addition of 0.25% w/v putative inducers (arrow) i.e. maltotriose, pullulan or glucose.
The graphs show the means and standard deviations from two independent experiments. C. Relative expression of apuA genes following addition of
putative inducers to S. suis growing in CM plus lactose. D. Relative expression of apuA genes following addition of putative inducers. The relative
expression of apuA, was measured by qPCR 10, 30, 60 and 90 minutes after addition of the putative inducers, The height of the bars shows the mean
(n = 3) fold change in expression 6 SEM from two independent experiments. Statistical significance was calculated using a two-way ANOVA test
followed by Bonferroni’s post hoc test (* p,0.05; ** p,0.01; *** p,0.001.).
doi:10.1371/journal.pone.0089334.g004
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pullulan (0.40%60.01) (P,0.01) (Figure 6B), corresponding to
approximately 8.06102 cfu/ml when grown in glucose, to
7.26103 cfu/ml in pullulan. In conclusion, S. suis grown in
starch/pullulan showed a small but significant increase in
adherence to, and a strongly increased invasiveness of NPTr cells
compared to S. suis grown in glucose.
Carbon catabolite control of suilysin expression
The expression of sly was strongly induced in pullulan compared
to glucose, both in exponential and stationary phase (+18.1/+17.9
ratio in pullulan vs glucose). The presence of a cre site in the sly
promoter region suggested that the induction of sly during growth
in pullulan was due to relief from CcpA-mediated carbon
catabolite repression rather than a specific induction by starch/
pullulan. As suilysin has been proposed to compromise the
integrity of the host epithelium and facilitate entry into the body
we measured erythrocyte hemolytic activity (HA) of culture
supernatants of S. suis grown in glucose or pullulan. HA was
significantly higher in supernatants of S. suis grown in pullulan
compared to glucose over a wide range (ca. 0.5) of OD600 values
(P,0.001; Figure 7). In early stationary phase, HA for pullulan
and glucose cultures was approx. 91% and 18%, respectively
(Figure 7).
In vivo expression of the virulence factors apuA and sly
Based on the results from this study so far, we predicted that
expression of apuA and sly would be substantially higher in the
mucosal colonization stage of the infection when glucose is scarce
than in the bloodstream where glucose levels are sufficient to
support growth and induce CCR. S. suis invasive disease often
leads to infection of the joints, heart and brain. To test our
hypothesis S. suis was recovered from the blood, synovial joints,
heart and brains of infected piglets immediately after euthanasia
and RNA was extracted from the blood and organs. As
hypothesized we found transcription of sly and apuA to be
significantly higher in the synovial joints, heart and brain than
in the blood (Figure 8). These results show that our regulatory
Figure 5. Identification of conserved operator binding motifs for ApuR (OM1) and CcpA (OM2) in S. suis P1/7, B. subtilis 168 and L.
monocytogenes EDG-e. A. The 6 kb amylopullulanase gene apuA is located downstream of apuR which encodes a putative transcriptional regulator
of the LacI/GalR family. Located downstream of apuA are a cluster of genes predicted to be involved in uptake and fermentation of ascorbate (sgaT,
sgaB). For each gene, the direction of transcription is indicated by an arrow, the size of which is proportional to the length of the corresponding open
reading frame. Putative promoters are represented by arrows and transcription terminators by loops. The operator motifs OM1 and OM2/cre (shaded
sequences in B, C and D) were determined using the MEME software suite and their relative probability p-values are indicated. B. The apuA promoter
based on the experimentally determined transcription start site (Ts arrow) C. The B. subtilis mdxE (BSU34610) promoter D. The L. monocytogenes
lmo2125 promoter E. and F. Sequence alignment of the DNA binding domains of the ApuR and CcpA proteins of S. suis, L. monocytogenes and B.
subtilis. Conserved amino acid sequences are indicated in black.
doi:10.1371/journal.pone.0089334.g005
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model (Figure 9) was informative for some aspects of porcine
infection with S. suis.
Discussion
Asymptomatic carriage of S. suis is common in adult pigs but
young piglets that become colonized by S. suis may develop
invasive disease. Host susceptibility to S. suis infection may occur
due to inadequate host immune responses but may also be due to
environmental factors such as the availability of glucose or other
Figure 6. Comparison of adherence A. and invasion B. of S. suis after growth in CM+1% w/v pullulan (black bars) vs. CM+1% w/v
glucose (white bars). NPTr confluent monolayers were co-cultivated for 2 h with S. suis S10 bacteria grown in CM plus pullulan or glucose.
Adherence and invasion are shown as mean % values of the initial inoculum from two independent experiments in triplicate. Error bars indicate the
SD.
doi:10.1371/journal.pone.0089334.g006
Figure 7. Hemolysis assay of S. suis growing in two different
carbon sources. A. The hemolysis production was measured by
analyzing the supernatant of S. suis grown in CM plus 1% w/v of
glucose or pullulan in the lag, exponential and stationary phase (OD600
values 0 to 0.56). B. Deep-well titer plate showing hemolytic activity of
supernatants collected from S. suis grown in CM supplemented with
glucose or pullulan.
doi:10.1371/journal.pone.0089334.g007
Figure 8. Expression of apuA and sly in S. suis recovered from
blood and tissues of experimentally infected piglets. The relative
expression of apuA and sly in S. suis blood, joints, heart and brain
recovered from intravenously infected piglets calculated using the
GeNorm method [38] using three housekeeping genes for data
normalization. A. The relative expression of apuA (6107) are shown
for S. suis recovered from blood and different organs. B. Relative
expression of sly (6105) in blood and different organs.
doi:10.1371/journal.pone.0089334.g008
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carbohydrates. Here we investigated whether the availability of
different types of carbohydrates, notably starch and glucose, could
influence the switch from an asymptomatic to a pathogenic
association of S. suis with the host. To search for the mechanism
controlling such a switch, we initially performed an in vitro
transcriptomics study on S. suis grown in CM medium supple-
mented with pullulan or glucose; the latter mediates carbon
catabolite control in streptococci via catabolite control protein A
(CcpA). Pullulan, a starch, was chosen since we had previously
found that growth of S. suis in presence of this carbohydrate
induces expression of apuA, a gene known to be involved in
carbohydrate metabolism [19].
A switch from growth in glucose to starch/pullulan resulted in a
change of ca. 50% of its transcriptome, involving multiple GO
function categories (Figure 1). As anticipated many genes
annotated with GO term ‘‘carbohydrate metabolism’’ were
differentially expressed, including the a-glucan-starch-degrading
amylopullulanase apuA [19] and downstream pathway genes
required for maltodextrin metabolism (Figure 2).
In other streptococcal pathogens CcpA and CCC have been
shown to play a role in virulence gene expression as well as
colonization [50,51] and virulence in an animal model [51]. To
predict which S. suis genes might be regulated by CCC we
searched for conserved cre sites in the genome of S. suis P1/7 and
identified 172 genes, some of which were organized in operons
(Table S3). Of these 172 genes, 145 (84%) were differentially
regulated during growth in pullulan compared to glucose. The
difference in these two values may be due to incorrect cre site
predictions or to the fact that expression of certain genes or
operons are controlled by additional transcription factors, for
example suilysin may be also co-regulated by the two-component
system CovS/CovR (SSU1190-SSU1191) [52]. The 145 genes
that appeared to be controlled by CCC were also compared to a
published microarray data set generated by comparison of an S.
suis serotype 2 DccpA mutant with the corresponding wild-type
strain [43]. In total, 99 genes comprising 38 operons were
differentially regulated in both datasets (68% overlap; Table S3).
The CCC-regulon included genes encoding transcriptional
regulators, carbohydrate metabolic enzymes and, importantly,
putative or known virulence factors (8%) (Table S3). The most
highly up-regulated virulence gene in pullulan compared to
glucose was apuA encoding a cell-surface amylopullulanase
required for growth on starch or glycogen that also contributes
to adherence to porcine epithelial cells in vitro and thus may be
relevant to mucosal colonization [19]. Expression of apuA was
highly induced during growth in starch/pullulan or maltotriose,
the most abundant degradation product of pullulan, and repressed
during growth in glucose (Figure 3 and 4). An analysis of the
promoter region of apuA revealed the presence of two transcription
binding motifs (Figure 5) and EMSA studies showed that apuA
expression was co-regulated by CcpA and a second regulator,
ApuR (Figure S6). The similar location of the conserved OM in
the promoters regulated by ApuR and the known transcriptional
activator of maltodextrin utilization cluster Lmo2128 in L.
monocytogenes [47] and MdxR in E. faecium [48], with high sequence
similarity to ApuR, suggested that ApuR might also be a
transcriptional activator. Addition of maltotriose to S. suis
exponentially growing in medium containing lactose as a carbon
source, significantly induced expression of apuA and, to a lesser
extent, apuR suggesting that ApuR, like Lmo2128, might be
allosterically regulated by maltotriose (Figure 4). In contrast, CcpA
binding repressed apuA transcription, most likely through binding
to an OM2/cre site overlapping with the 235 promoter element,
since addition of maltotriose to S. suis bacteria precultured in
glucose as sole carbon source did not lead to significant induction
of apuA. This dual regulatory model postulates that apuA is
maximally expressed when glucose level is low, thus allowing relief
from CcpA-mediated catabolite repression, and when substrates
that can be degraded by apuA are present.
In addition to apuA, eighteen other predicted or known
virulence genes were differentially regulated in pullulan vs glucose,
seven of which were highly upregulated in pullulan compared to
glucose (Table 1, Figure S3). One of these genes was sly encoding
suilysin, a pore-forming toxin which was secreted in 5-fold higher
amounts in pullulan compared to glucose (Figure 7); its increased
expression was confirmed in qPCR assays (Figure 3). Suilysin plays
an important role in damaging host epithelial [12,13,53],
endothelial [54,55] and immune cells [56], suggesting that suilysin
could play roles in vivo in damaging and penetration of different
cell and tissue types, promoting tissue invasion and inhibition or
killing of leukocytes [3,57]. Of note, virulent S. suis strains that do
not produce Sly may still be invasive in pigs, possibly best
Figure 9. Links between carbohydrate metabolism and virulence in Streptococcus suis. At the mucosal surfaces a high ratio of a-glucans to
glucose upregulates expression of several sugar transport systems and metabolic pathways associated with starch metabolism. Additionally, several
virulence factors involved in adherence to host cells, degradation of connective tissue (spreading factors), and avoidance of phagocytic killing,
including ApuA and suilysin are upregulated when glucose is diminished. Suilysin may facilitate dispersion of bacteria in mucosal tissues due to loss
of barrier integrity. Once S. suis reaches the bloodstream metabolism is adapted for optimal growth on glucose and the expression of virulence
factors is reduced by CcpA mediated-repression. In infected organs glucose levels are lower than in the blood and are further reduced by
inflammation and utilization by S. suis leading to upregulation of ApuA, suilysin and other virulence factors. In the organs and tissues, glycogen
released from damaged cells is degraded by ApuA to generate maltodextrins which sustain growth of S. suis.
doi:10.1371/journal.pone.0089334.g009
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exemplified by Allen et al (2001) [58] who reported that an isogenic
S. suis sly mutant, lacking of the hemolytic characteristics, was
nearly as invasive as the wild-type parental strain in a pig infection
studies after bacteria intravenous injection. The authors of the
study by Allen et al (2001) [58] proposed that Sly is relevant for
translocation across epithelia and during the infection stages prior
to dispersion via the blood, and proposed that production of Sly
may correlate with increased severity of clinical symptoms and the
capacity to reach higher colonization of organs. This notion is
supported by the study of King et al (2001) [59] who reported that
sly was present in a significantly higher number of isolates from
pigs with meningitis, septicemia, and arthritis than isolates from
pigs with pneumonia. Conversely, sly is also significantly overrep-
resented in asymptomatic carriage strains of pigs [59], showing
that presence of sly does not exclusively correlate with invasive
isolates. In addition to suilysin, it is likely that other virulence
factors are relevant for the invasion of connective tissue, such as
the hyaluronidase and heparinase II/III-like proteins. Note that
the function of these putative virulence proteins still has to be
demonstrated. In contrast to our results, sly expression was not
increased in a recent study which compared gene expression of a
wild-type strain with a DccpA mutant grown to stationary phase
[43]. The reason for these different findings may be related to the
use of THB growth medium [43], a rich medium containing
glucose, instead of the supplemented CM medium that we used, or
different growth stages or different physiological states of the
bacteria in the different media. Lastly, it is also possible that
expression of sly is controlled by a CcpA-independent carbon
catabolite repression mechanism although a cre site is present in
the sly promoter region.
We propose that at mucosal surfaces the high ratios of starch to
glucose promotes production of extracellular ApuA to support
growth of S. suis in the oropharyngeal cavity. Additionally relief
from CCR leads to higher expression of other virulence genes
involved in mucosal infection (Figure 9). Indeed, in an in vitro
experiment employing tracheal epithelial cells and S. suis bacteria
grown with starch/pullulan or glucose as sole carbon source, a
nearly 10-fold increase of epithelial cell invasion was observed
when bacteria were grown with pullulan. We observed that in
presence of starch, S. suis induced expression of the metabolic
pathway enzymes required for transport and metabolism of
maltodextrins and the glycogen biosynthesis enzymes which
generate bacterial glycogen energy reserves. Several studies have
linked bacterial glycogen metabolism to environmental survival,
symbiotic performance, and colonization and virulence [60–67].
Glycogen reserves may be important for survival and fitness of S.
suis when carbon sources are scarce. During colonization, relief
from CCR would increase production of suilysin and may
facilitate dispersion of S. suis into the deeper tissues due to loss
of barrier integrity [4,53,58]. We hypothesized that once S. suis
would reach the bloodstream, higher glucose concentrations (from
4.4 to 6.6 mM) would repress expression of apuA and sly by CCR
(Figure 9). Indeed, gene expression analysis of bacteria isolated
from the blood or organs of acutely infected pigs showed
significantly lower expression of apuA and sly in blood than in
the organs (Figure 8) supporting occurrence of CCR. In contrast,
S. suis isolated from infected joints, heart or brain tissue expressed
significantly higher levels of sly and apuA than bacteria isolated
from blood. These results are probably due to the lower levels of
glucose in the tissues (0.25–0.55 mM in normal synovial fluid and
joint cavities) than in the blood (from 4.4 to 6.6 mM) [68,69] and
thus, relief from CCR when bacteria were located in the organs. In
inflamed tissues, glucose levels may have been reduced further due
to the consumption of glucose by neutrophils and macrophages. It
is tempting to speculate that induction of suilysin expression in the
tissues will release host glycogen from damaged cells that would be
degraded by ApuA and metabolized to further support growth of
S. suis (Figure 9). Additionally S. suis may be able to metabolize
host glucans such as hyaluronan which is present in high
concentrations (3–4 mg/ml) in synovial fluid [70].
Taken together, our results clearly demonstrate that the
availability of glucose and other carbohydrates such as starch serves
as an environmental cue to regulate the expression of apuA and other
virulence genes. We propose a schematic model of how carbohy-
drate content of different tissues could modulate S. suis metabolism
at the different stages of infection (Figure 9). Our novel findings
demonstrate a regulatory mechanism dependent on relief from
CcpA repression that links carbohydrate metabolism and virulence
at least in vitro and that might play roles in vivo, at different stages of S.
suis infection. Awareness of the role of carbohydrate content of the S.
suis environment may lead to new strategies for combating this
important disease, for instance via modulation of carbohydrate
content and composition of animal feeds, or the inhibition of S. suis
enzymes required for metabolism of starch.
Supporting Information
Figure S1 S. suis S10 growth curve at 37uC in CM containing
pullulan or glucose at 1% w/v.
(TIF)
Figure S2 GO term distribution of S. suis genes with the
annotation ‘‘carbohydrate metabolism’’ that were differentially
upregulated in starch/pullulan vs glucose. A. early exponential (e)
and B. early stationary phase (s) Enrichment analysis performed
using BLAST2GO (P= 0.05, two-tailed Fisher’s Exact test).
(TIF)
Figure S3 Putative and characterized virulence gene expression
ratios in pullulan vs. glucose. The genes are grouped according to
their predicted or described function in S. suis pathogenesis and
expression ratios are shown for exponential (white bar) and early
stationary (black bar) growth phases. Envelope: cps2E*-SS0519
putative galactosyl transferase; wchF*-SSU0520 putative rhamno-
syl transferase; cps2C-SSU0517 tyrosine-protein kinase; cpss_lpl-
SSU1123 putative glycosyltransferase; cpss_lpl2-SSU1124 putative
rhamnosyl transferase pgdA-SSU1448 peptidoglycan GlcNAc
deacetylase, dltA-SSU0596 D-alanine-poly(phosphoribitol) ligase
subunit1; Envelope/Adhesion neuB-SSU0535 putative N-acetyl-
neuraminic acid synthase; neuC-SSU0536 putative UDP-N
acetylglucosamine 2-epimerase; neuA-SSU0538 N-acylneurami-
nate cytidylyltransferase; Adhesion: apuA*-SSU1849 amylopullu-
lanase; sadP-SSU0253 putative surface-anchored protein receptor;
gnd-SSU1541 6-phosphogluconate dehydrogenase; Adhesion/In-
vasion: srtA-SSU0925 sortase; fbpS-SSU1311 fibronectin-fibrino-
gen binding protein; gapdH-SSU0153 glyceraldehyde-3-phosphate
dehydrogenase; eno-SSU1320 enolase; pepD-SSU1215 putative
surface-anchored dipeptidase; dpp IV-SSU0187 Xaa-Pro dipepti-
dyl-peptidase; Invasion: sly* SSU1231 suilysin (haemolysin); hepII/
III*-SSU1048 heparinase II/III-like protein; hyl*-SSU1050 hyal-
uronidase precursor; ssnA*-SSU1760 surface-anchored DNA
nuclease; arcB*-SSU0580 arginine deaminase; igaP-SSU1773
putative surface-anchored serine protease; sspA-SSU0757 cell
envelope proteinase; ofs-SSU1474 serum opacity factor; luxS-
SSU0376 S-ribosyl homocysteinase; Marker: mrp-SSU0706 mu-
ramidase-released protein precursor; ef-SSU0171 putative surface-
anchored protein. * Indicates the presence of a predicted cre in the
virulence gene promoter region.
(TIF)
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Figure S4 Gene homologues in Gram-positive bacteria that
share $45% of protein identity with the S. suis apuR gene (black
arrows). The annotations of the genes downstream of apuR are also
indicated and colored to show functional relatedness. Gene names
are indicated above the arrows.
(TIF)
Figure S5 SDS polyacrylamide electrophoresis of purified
transcriptional regulators. A. Coomassie stained SDS-PAGE gel
(12%), showing purified fraction His-ApuR at the expected size of
38 kDa and B. Western Blot of the same gel with a monoclonal
His-tag antibody protein. C. Coomassie stained SDS-PAGE gel
(12%) of purified His-CcpA at expected size of 40 kDa.
(TIF)
Figure S6 EMSA with purified ApuA and CcpA. A. Schematic
representation of the apuA promoter (PapuA) and fluorescently
labeled PCR amplified DNA fragments (Pr1, Pr2 and Pr3) used for
EMSAs. B. to F. DNA amplicons and DNA/rApuR protein
complexes visualized in native 5% acrylamide gels using the
Odyssey Imager. In these EMSA assays the concentration of each
DNA amplicon was around 6 ng (,50 nM) B. EMSA of 100 nM
rApuR binding to Pr1, Pr2 and Pr3. C. Increasing DNA/rApuR
complex formation in presence of 4 ng Pr2 DNA amplicon and an
increasing amount of rApuR (,0,5–4 mM as indicated) D.
Competitive EMSA using increasing concentrations of non-
fluorescent non-specific competitor DNA (lacking OM1 binding
motifs). E. Competitive EMSA using increasing concentrations of
non-fluorescent Pr2 as a specific competitor. The amounts of
competitor DNA added are indicated (25–150 nM) F. Identifica-
tion of specific ApuR binding sites in PapuA. PR2: native promoter
region fragment 2. DOM1 and DOM2/cre are synthetic DNA
fragments of PapuA that lack the predicted binding sites. + rApuR
recombinant present - rApuR recombinant absent. G. to J. DNA
amplicons and DNA/rCcpA protein complexes visualized in
native 5% acrylamide gels using the Odyssey Imager. G. DNA/
rCcpA complexes in the presence of increasing amounts of rCcpA
as indicated. H. Competitive EMSA using increasing concentra-
tions of non-fluorescent specific competitor I. Competitive EMSA
using increasing concentrations of non-fluorescent non-specific
competitor DNA (lacking OM2/cre binding motifs) J. DNA/
rCcpA complex formation with fluorescent Pr2 and two synthetic
promoter Pr2 fragments lacking either OM2/cre or OM1.
(TIF)
Table S1 Oligonucleotide primers used in this study.
(DOCX)
Table S2 Microarray data (xl file): S. suis genes differentially
regulated during growth in pullulan (Pul) vs glucose (Glc) in the
exponential (e) or stationary (s) phase.
(XLSX)
Table S3 cre-site prediction in the genome of S. suis P1/7.
(DOCX)
Table S4 Motif OM1-OM2/cre like motifs identified in S. suis 2
P1/7 and other Gram positive bacteria.
(DOCX)
Text S1 Material and methods.
(DOCX)
Text S2 Results (Supporting text on differentially expressed
genes, pathways and their predicted or known functions).
(DOCX)
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